Gianmarco Melone
Gianmarco Melone is a PhD student enrolled in a joint PhD program between Swansea University and Houston Methodist Research Institute. Currently involved in active research to define the role of inducible Nitric Oxide Synthase (iNOS) in the tumour niche of the High Grade Serous Ovarian Cancer (HGSOC) and Triple Negative Breast Cancer (TNBC). Gianmarco worked at Swansea University to develop an innovative RNAi interference therapy based on miRNAs with the aim of destabilizing the ovarian cancer tumour niche. He got his master’s degree in molecular biology in Italy, at Università Politecnica delle Marche working in the NY-MaSBiC laboratories to develop an advanced graphene system for SARS-CoV-2 detection during the world pandemic
Tejaswini Reddy
Tejaswini (Teja) Reddy received a bachelor’s of arts in neuroscience from Wellesley College in 2015. She matriculated into the Texas A&M MD/PhD program in 2016 and joined Dr. Jenny Chang’s Lab in April 2019. Prior to joining the MD/PhD program, Reddy gained research experience at various institutions, including Oregon Health and Science University, Wellesley College, Indian Council for Medical Research, The Edwin L. Steele Laboratory for Tumor Biology at Massachusetts General Hospital, and Texas Tech University Health Science Center. Her research currently involves studying novel therapeutics to treat metaplastic breast cancer, a rare and highly aggressive cancer. In her free time, Reddy enjoys doing yoga, cooking, and traveling.
Wei Qian
Before joining Dr. Jenny Chang’s Lab, Wei Qian worked in a molecular and cellular biology lab at Baylor College of Medicine for more than ten years. She joined Dr. Jenny Chang’s Lab as a research assistant in May 2012. Qian primarily assists in the animal maintenance, projects, treatment, surgery, and several other aspects. She also is essential in helping fellow coworkers and students by maintaining the mouse model supply, performing IHC staining, preserving a tissue bank for all clinical samples, training new employees, creating and keeping lab sample inventory, analyzing data, and many other aspects involving the lab. In her spare time, Qian enjoys outdoor activities, cooking, and watching movies.
Jianying Zhou
Jianying Zhou received her bachelor’s in public health from Shanghai Medical University and practiced as a Certificated Nurse in China for more than 15 years before moving to the United States. She joined Dr. Jenny Chang’s Lab in April 2019 as a research assistant. Zhou assists in taking care of the experimental animals, mating, breeding, maintenance of PDX models and storage, mouse tumor implanting, and preforming treatment procedures. She also is involved in bench lab work, which includes recent involvement in a brain tumor metastasis project. In her spare time, Zhou enjoys traveling and watching movies.
Liliana Guzman, PhD
Liliana Guzman received her bachelor’s in clinical chemistry from the Autonomous University of Guadalajara, Mexico. Later, she obtained a master’s in immunology at the School of Medicine, National Autonomous University of Mexico, where she developed a diagnostic test for Chaga’s disease. Next, Guzman received her PhD from the Autonomous University of Nuevo Leon, and performed her research thesis at the Department of Immunology at MD Anderson Cancer Center, studying the transcriptional control of B-lymphocyte maturation in immune response. She continued her postdoctoral training in the Department of Genitourinary Medical Oncology at MD Anderson Cancer Center in Dr. Pasqualini and Dr. Arap lab developing new Phage Display technology and angiogenesis using genetically engineered mouse models. Then, Guzman was recruited by Dr. Nancy Jenkins and Dr. Neal Copeland at the Houston Methodist Research Institute in the Department of Cancer Research working in new approaches to sequence the insertion of transposons in the mouse genome by using next generation sequencing. In addition, she collaborated in the functional validation of novel tumor suppressors in breast cancer identified by transposon mutagenesis. Dr. Guzman then transferred to Dr. Jenny Chang’s Lab at the Cancer Center of Excellence in January 2019. She is involved in the characterization of transcriptional regulation of pathological angiogenesis in triple negative breast cancer. In her past time, Guzman enjoys being around her family and traveling.
Maria Chervo , PhD
Dr. Chervo is a postdoctoral fellow specializing in cancer immunotherapy, with a primary focus on developing personalized mRNA-based vaccines for the treatment of triple-negative breast cancer (TNBC). She earned her Ph.D. from the University of Buenos Aires, Argentina, where her research centered on RNA alternative splicing and the development of RNA interference (RNAi) therapeutics tailored for TNBC patients. Her current work leverages her expertise in tumor immunology, mRNA synthesis, and nanodelivery systems to design innovative treatments aimed at improving outcomes for patients with challenging, treatment-resistant cancers. In her research, Dr. Chervo employs advanced preclinical platforms, including humanized mouse models with patient-derived xenografts (PDXs), to closely mimic human tumor biology and immune responses. Outside of her research, Dr. Chervo enjoys spending quality time with her family and friends. She is a devoted dog lover, often exploring the outdoors with her furry companions.